Concord Wealth Partners Novartis Ag Transaction History
Concord Wealth Partners
- $603 Million
- Q4 2024
A detailed history of Concord Wealth Partners transactions in Novartis Ag stock. As of the latest transaction made, Concord Wealth Partners holds 1,398 shares of NVS stock, worth $161,427. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,398
Previous 1,705
18.01%
Holding current value
$161,427
Previous $196,000
30.61%
% of portfolio
0.02%
Previous 0.03%
Shares
19 transactions
Others Institutions Holding NVS
# of Institutions
1,479Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.41 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.27 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$945 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$793 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$644 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $248B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...